7/14/2020

Mupirocin Calcium 2% Cream

Products Affected - Description

- Bactroban topical cream, GlaxoSmithKline, 2%, 15 gm tube, 1 count, NDC 00029-1527-22 - discontinued
- Bactroban topical cream, GlaxoSmithKline, 2%, 30 gram tube, 1 count, NDC 00029-1527-25 - discontinued

Reason for the Shortage

- GlaxoSmithKline discontinued Bactroban 2% cream in June 2020.
- Glenmark has mupirocin cream available.

Available Products

- Mupirocin calcium topical cream, Glenmark, 2%, 15 gram tube, 1 count, NDC 68462-0564-17
- Mupirocin calcium topical cream, Glenmark, 2%, 30 gram tube, 1 count, NDC 68462-0564-35

Updated

Updated July 14, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created September 4, 2015 by Jane Chandramouli, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.